luteolin + dexamethasone

Luteolin + dexamethasone is a combination of two agents—luteolin, a naturally occurring flavonoid with anti-inflammatory and antioxidant properties, and dexamethasone, a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive effects. This combination has been studied in preclinical models for its synergistic effects in reducing inflammation, oxidative stress, and tissue damage. In particular, low-dose dexamethasone combined with luteolin has demonstrated improved recovery after myocardial infarction by activating the Keap1/Nrf2/HO-1 antioxidative pathway, leading to reduced reactive oxygen species (ROS) production and pro-inflammatory cytokines while enhancing antioxidative enzyme expression[1][2]. Luteolin itself also modulates multiple inflammatory pathways (including NF-κB and MAPK), enhances antioxidant defenses, and may interact with GABAA receptors to provide neuroprotective effects[4][6]. The combination is experimental; it is not an approved pharmaceutical product but rather an investigational pairing explored for potential cardioprotective or anti-inflammatory benefits.